Financial Statement

Fiscal Year Ends	:	December
( in million Rupiah except Par Value, Per Share Data and Ratios )
Statement Date	:	2024-03-31
Balance Sheet
Cash & Cash Equivalents	:	4
Curr. Assets	:	10
Fixed Assets	:	26
Total Assets	:	36
Curr. Liabilities	:	3
Long Term Debt	:	11
Minority Interest	:	0
Total Liabilities	:	15
Paid-Up Capital	:	550
Total Equity	:	21
Income Statement
Total Sales	:	5
Gross Profit	:	1
Operating Profit	:	0
Net Income	:	0
Cash Flow Statement
Cash From Operating Act	:	2
Cash From Investing Act	:	-1
Cash From Financing Act	:	0
Per Share Data (in IDR)
EPS	:	5.25
Book Value	:	603.47
Financial Ratios
Der	:	0.69
Roa	:	0.15
Roe	:	0.03
Npm	:	0.04
Opm	:	0.05
Growth Year to Year
Sales (%)	:	100.00%
Net Income (%)	:	100.00%
Total Assets (%) (%)	:	100.00%
Total Liabilities (%)	:	100.00%

1	RAK ICC Provides Strategic Solutions for Holding Companies and Regional Expansion

2	Illumina and PREMIA partner to expand clinical access to CGP in Asia

3	Rokid and Ant International Announce Integration of Smart Glasses Payment Capability

4	Salcomp's Debut on CES 2026

5	Call for Application for 2026 Tsinghua Amgen Scholars Program

RAK ICC Provides Strategic Solutions for Holding Companies and Regional Expansion